PDE4A and amyloidosis: There was a remarkable amendment in the architecture of the brain and less amyloidosis, together with decreased levels of inflammatory cytokines and upregulation of cAMP, PKA, CREB and BDNF, which may result from the augmented inhibition of PDE4.